全文获取类型
收费全文 | 84345篇 |
免费 | 4390篇 |
国内免费 | 45篇 |
专业分类
林业 | 3956篇 |
农学 | 2845篇 |
基础科学 | 490篇 |
11368篇 | |
综合类 | 10193篇 |
农作物 | 3062篇 |
水产渔业 | 4132篇 |
畜牧兽医 | 46923篇 |
园艺 | 990篇 |
植物保护 | 4821篇 |
出版年
2019年 | 789篇 |
2018年 | 1436篇 |
2017年 | 1583篇 |
2016年 | 1465篇 |
2015年 | 1136篇 |
2014年 | 1463篇 |
2013年 | 3737篇 |
2012年 | 2523篇 |
2011年 | 3090篇 |
2010年 | 2096篇 |
2009年 | 2011篇 |
2008年 | 2923篇 |
2007年 | 2900篇 |
2006年 | 2654篇 |
2005年 | 2361篇 |
2004年 | 2254篇 |
2003年 | 2232篇 |
2002年 | 2017篇 |
2001年 | 2918篇 |
2000年 | 2761篇 |
1999年 | 2176篇 |
1998年 | 878篇 |
1997年 | 813篇 |
1996年 | 763篇 |
1995年 | 899篇 |
1994年 | 761篇 |
1992年 | 1601篇 |
1991年 | 1732篇 |
1990年 | 1805篇 |
1989年 | 1682篇 |
1988年 | 1541篇 |
1987年 | 1533篇 |
1986年 | 1482篇 |
1985年 | 1394篇 |
1984年 | 1207篇 |
1983年 | 976篇 |
1979年 | 1206篇 |
1978年 | 907篇 |
1977年 | 804篇 |
1976年 | 929篇 |
1975年 | 940篇 |
1974年 | 1099篇 |
1973年 | 1033篇 |
1972年 | 1025篇 |
1971年 | 918篇 |
1970年 | 927篇 |
1969年 | 926篇 |
1968年 | 869篇 |
1967年 | 897篇 |
1966年 | 829篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
971.
A comparison of clinical,magnetic resonance imaging and pathological findings in dogs with gliomatosis cerebri,focusing on cases with minimal magnetic resonance imaging changes‡ 下载免费PDF全文
R. T. Bentley G. N. Burcham H. G. Heng J. M. Levine R. Longshore S. Carrera‐Justiz K. Kopf M. A. Miller 《Veterinary and comparative oncology》2016,14(3):318-330
The primary study objective was to determine whether clinical examination and magnetic resonance imaging (MRI) can underestimate canine gliomatosis cerebri (GC); we also investigated immunohistochemical features. Seven dogs with GC were studied; four recruited specifically because of minimal MRI changes. Neuroanatomic localization and the distribution of MRI, gross and sub‐gross lesions were compared with the actual histological distribution of neoplastic cells. In six cases, clinical examination predicted focal disease and MRI demonstrated a single lesion or appeared normal. Neoplastic cells infiltrated many regions deemed normal by clinical examination and MRI, and were Olig2‐positive and glial fibrillary acid protein‐negative. Four dogs had concurrent gliomas. GC is a differential diagnosis for dogs with focal neurological deficits and a normal MRI or a focal MRI lesion. Canine GC is probably mainly oligodendrocytic. Type II GC, a solid glioma accompanying diffuse central nervous system neoplastic infiltration, occurs in dogs as in people. 相似文献
972.
Differentiation between dogs with thrombosis and normal dogs using the overall hemostasis potential assay 下载免费PDF全文
Anna L. Dengate BVSc BMedSc Marie‐Christine Morel‐Kopp PhD Julia A. Beatty PhD BVetMed BSc Vanessa Barrs BVSc MVetClinStud Jody A. Braddock BVSc MVetClinStud Richard K. Churcher BVSc Bethany J. Wilson BVSc PhD Christopher M. Ward BMedSc MBChB PhD 《Journal of Veterinary Emergency and Critical Care》2016,26(3):446-452
973.
Severe hyperkalemia presenting with wide‐complex tachycardia in a puppy with acute kidney injury secondary to leptospirosis 下载免费PDF全文
974.
Development and characterization of a technique for percutaneous radiologic gastrojejunostomy tube placement in the dog 下载免费PDF全文
975.
Validation of the Accutrend Plus point‐of‐care triglyceride analyzer in horses,ponies, and donkeys 下载免费PDF全文
976.
Percutaneous absorption of chemicals: developing an understanding for the treatment of disease in frogs 下载免费PDF全文
V. K. Llewelyn L. Berger B. D. Glass 《Journal of veterinary pharmacology and therapeutics》2016,39(2):109-121
The permeable nature of frog skin presents an alternative route for the delivery of therapeutic chemicals to treat disease in frogs. However, although therapeutic chemicals are often topically applied to the skin of frogs, their pharmacokinetics have rarely been reported. To provide evidence to guide both candidate drug and formulation selection, we highlight factors expected to influence percutaneous absorption through frog skin, including the anatomy and physiology of the skin and the physicochemical properties of applied therapeutic chemicals. Importantly, we also highlight the effects of the formulation on percutaneous absorption, especially the inclusion of potential penetration enhancers as excipients. Finally, we collate empirical data on the topical application of various therapeutic chemicals in postmetamorphic frogs and show that, in contrast to mammalian species, even large chemicals (i.e. >500 Da) and those with a wide range of log P values (?4 through +6) are likely to be absorbed percutaneously. Topical application in frogs thus promises a convenient and effective method for delivering systemic treatments of a diverse range of chemicals; however, further experimental quantification is required to ensure optimal outcomes. 相似文献
977.
Anatomical and physiological basis for the allometric scaling of cisplatin clearance in dogs 下载免费PDF全文
S. Achanta A. Sewell J. W. Ritchey K. Broaddus D. W. A. Bourne C. R. Clarke L. K. Maxwell 《Journal of veterinary pharmacology and therapeutics》2016,39(3):224-236
Cisplatin is a platinum‐containing cytotoxic drug indicated for the treatment of solid tumors in veterinary and human patients. Several of the algorithms used to standardize the doses of cytotoxic drugs utilize allometry, or the nonproportional relationships between anatomical and physiological variables, but the underlying basis for these relationships is poorly understood. The objective of this proof of concept study was to determine whether allometric equations explain the relationships between body weight, kidney weight, renal physiology, and clearance of a model, renally cleared anticancer agent in dogs. Postmortem body, kidney, and heart weights were collected from 364 dogs (127 juveniles and 237 adults, including 51 dogs ≥ 8 years of age). Renal physiological and cisplatin pharmacokinetic studies were conducted in ten intact male dogs including two juvenile and eight adult dogs (4–55 kg). Glomerular filtration rate (GFR), effective renal plasma flow, effective renal blood flow, renal cisplatin clearance, and total cisplatin clearance were allometrically related to body weight with powers of 0.75, 0.59, 0.61, 0.71, and 0.70, respectively. The similar values of these diverse mass exponents suggest a common underlying basis for the allometry of kidney size, renal physiology, and renal drug handling. 相似文献
978.
Elimination of cetirizine following administration of multiple doses to exercised thoroughbred horses 下载免费PDF全文
H. K. Knych S. D. Stanley R. M. Arthur D. S. McKemie 《Journal of veterinary pharmacology and therapeutics》2016,39(5):522-524
Cetirizine is an antihistamine used in performance horses for the treatment of hypersensitivity reactions and as such a withdrawal time is necessary prior to competition. The objective of the current study was to describe the disposition and elimination of cetirizine following oral administration in order to provide additional serum concentration data upon which appropriate regulatory recommendations can be established. Nine exercised thoroughbred horses were administered 0.4 mg/kg of cetirizine orally BID for a total of five doses. Blood samples were collected immediately prior to drug administration and at various times postadministration. Serum cetirizine concentrations were determined and selected pharmacokinetic parameters determined. The serum elimination half‐life was 5.83 ± 0.841 h. Average serum cetirizine concentrations were still above the LOQ of the assay (0.05 ng/mL) at 48 h (final sample collected) postadministration of the final dose. 相似文献
979.
Pharmacokinetic study of meropenem in healthy beagle dogs receiving intermittent hemodialysis 下载免费PDF全文
S. Y. Byun J. W. Jeong J. H. Choi K. P. Lee H. Y. Youn H. J. Maeng K. H. Song T. S. Koo K. W. Seo 《Journal of veterinary pharmacology and therapeutics》2016,39(6):560-565
Meropenem, a second carbapenem antimicrobial agent with a broad spectrum of activity, is used to treat sepsis and resistant‐bacterial infections in veterinary medicine. The objective of this study was to identify the pharmacokinetics of meropenem in dogs receiving intermittent hemodialysis (IHD) and to determine the proper dosing in renal failure patients receiving IHD. Five healthy beagle dogs were given a single i.v. dose of 24 mg/kg of meropenem and received IHD. The blood flow rate, dialysate flow, and ultrafiltration rate were maintained at 40 mL/min, 300 mL/min, and 40 mL/h, respectively. Blood samples were collected for 24 h from the jugular vein and from the extracorporeal arterial and venous line. Urine samples and dialysate were also collected. The concentrations of meropenem were assayed using HPLC/MS/MS determination. The peak plasma concentration was 116 ± 37 μg/mL at 15 min. The systemic clearance was 347 ± 117 mL/h/kg, and the steady‐state volume of distribution was 223 ± 67 mL/kg. Dialysis clearance was 71.1 ± 34.3 mL/h/kg, and the extraction ratio by hemodialysis was 0.455 ± 0.150. The half‐life (T1/2) in dogs with IHD decreased compared with those without IHD, and the reduction in T1/2 was greater in renal failure patients than in normal patients. Sixty‐nine percent and 21% of the administered drug were recovered by urine and dialysate in the unchanged form, respectively. In conclusion, additional dosing of 24 mg/kg of meropenem after dialysis could be necessary according to the residual renal function of the patient based on the simulated data. 相似文献
980.
D. Love P. Gibbons V. Fajt M. Jones 《Journal of veterinary pharmacology and therapeutics》2016,39(3):305-308
Ponazuril (toltrazuril sulfone) is a triazine antiprotozoal agent that targets apicomplexan organisms. Ponazuril may have clinical application in the treatment of clinical coccidiosis due to Eimeria species in goats, along with other protozoal infections. To evaluate the absorption, distribution and elimination characteristics of ponazuril in goats, a sensitive, validated high‐pressure liquid chromatography and mass spectroscopy method for ponazuril in caprine plasma was developed. After a single oral dose of ponazuril at 10 mg/kg, plasma samples from seven weanling goats were collected and assayed. Plasma concentrations of ponazuril in the goats peaked at 36 ± 13 h post drug administration at a concentration of 9 ± 2 μg/mL. Concentrations declined to an average of 4.2 ± 0.8 μg/mL after 168 h with an average elimination half‐life of 129 ± 72 h post drug administration. This study shows that ponazuril is relatively well absorbed after a single oral dose in goats. Efficacy trials are underway to determine clinical efficacy of ponazuril in the treatment of clinical coccidiosis in goats at 10 mg/kg dosage. 相似文献